Awarded for original scientific work of intrinsic scientific importance and with significant, beneficial applications in industry. The recipient is awarded a $25,000 prize. Established by the IBM Corporation in honor of Ralph E. Gomory.
James C. Liao (2014, bio-energy)
For developing the technologies that enable the production of higher alcohols as drop-in fuel from sugars, cellulose, waste protein, or carbon dioxide.
H. Boyd Woodruff (2011, agriculture)
For leading the development of multiple antibiotics, vitamin B12, and the avermectins, the latter revolutionizing parasite treatment in livestock and humans.
Robert T. Fraley (2008)
For developing technologies that enabled the production of the world's first transgenic crops. These modified plants have increased productivity, reduced chemical use, and profoundly changed global agriculture.
Philip Needleman (2005)
For his groundbreaking contributions to our understanding of the metabolism of arachidonic acid in physiology and pathophysiology, which generates prostacyclin and thromboxane.
J. Craig Venter (2002)
For his vision in using expressed sequence tags in genetic analyses, his unique contributions to the sequencing of microbial genomes, and his leadership in mobilizing new methods and resources for sequencing the human genome.
Ralph F. Hirschmann (1999)
For his ingenuity in creative chemical design and synthesis directed to the commercial production of numerous essential pharmaceuticals, such as anti-inflammatory steroids and anti-hypertensive compounds.
John H. Sinfelt (1996)
For his discovery of the principle of bimetallic cluster catalysis and the consequent development of the catalyst widely used in making lead-free gasoline.
Nick Holonyak (1993)
For his profound impact on industry and on the daily lives of the people around the world through his prolific inventions in the area of semiconductor materials and devices, including practical light-emitting diodes.
Carl Djerassi (1990)
While making pioneering contributions to steroid chemistry, he invented the first successful oral contraceptive, then led the team that brought it to market and won its public acceptance.